Navigation Links
Danong Chen appointed CEO of Theranostics Health
Date:4/16/2008

ROCKVILLE, Md., April 16 /PRNewswire/ -- The Board of Managers of Theranostics Health, LLC, is pleased to announce that Dr. Danong Chen has been elected as the new President and CEO of Theranostics Health. Dr. Chen was previously the President and CEO of Tanox Inc., a publicly held biopharmaceutical company which was acquired by Genentech in 2007. Previously Dr. Chen was Vice-President of Strategy and Corporate Development at Tanox, responsible for guiding company strategy, evaluating new product opportunities and overseeing corporate development. Prior to her tenure at Tanox she served as a manager in the health care practice section at Arthur D. Little. Dr. Chen also holds a Ph.D. from Baylor College of Medicine in Houston, Texas as well as an MBA from Arthur D. Little School of Management in Boston, Massachusetts.

"I am very excited to join such a devoted, innovative and accomplished team and feel privileged to be given the opportunity by the Board to lead Theranostics Health, a company at the forefront of shaping a new paradigm of healthcare and disease management," Dr Chen noted. "We strongly believe that Danong's impressive scientific and business credentials combined with her proven management and leadership skills will enable Theranostics Health to achieve its true potential in the years ahead," said Dr. James Cooper, the Chairman of the Board.

About Theranostics Health

Theranostics Health is a privately held company founded in 2006. Its core technology is the breakthrough Reverse Phase Protein Microarray (RPMA) combined with Laser Capture Microdissection (LCM). The technology measures the activity of a large number of biomarkers, enabling pharmaceutical companies to accurately profile their drug candidates to facilitate efficient and effective drug development. More importantly, it enables physicians to tailor optimized therapies to their patients based on the biomarker profile of each individual patient, providing safer and more effective therapies. The technology, invented by the company's co-founders Drs. Emanuel Petricoin and Lance Liotta, was first published by them in 2001, has been featured in over 50 peer-reviewed publications and 20 scientific presentations within the past 2 years, and was successfully used in NCI-sponsored clinical trials. Currently, Theranostics Health is working with 5 of the top 10 global pharmaceutical companies in their drug R&D efforts. The company closed its seed financing of $5 million in 2007 and generated revenue in its first year of operations. For more information please email info@theranosticshealth.com or visit http://www.theranosticshealth.com.


'/>"/>
SOURCE Theranostics Health, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. eBioscience Corporation Announced Today That James Glynn Has Been Appointed to Its Board of Directors, Effective April 15, 2008
2. W. Thomas Hodgson appointed to board of Helix BioPharma Corp.
3. Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities
4. Mr. Richard Decker Appointed Technical Director of Edgewood Chemical Biological Center
5. Chris Tihansky Appointed President of In Vivo Cellular Imaging Leader Cellvizio Inc.
6. Newly Appointed Dilon Technologies President & CEO Robert G. Moussa Sees BSGI as ... Major Weapon in the Battle Against Cancer
7. Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.
8. Dr. Joseph L. Corriveau Appointed Director of Research and Technology
9. Lucid Expands Support Internationally: Dr. Colin Stahel appointed Director for Asia Pacific Region
10. David Mott Appointed Non Executive Director at Shire
11. Dr. David Sidransky Appointed Chairman of Champions Biotechnology, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
(Date:6/23/2016)... ... 2016 , ... Velocity Products, a division of Morris Group, ... exclusively for Okuma CNC machining centers at The International Manufacturing Technology Show, IMTS, ... companies with expertise in toolholding, cutting tools, machining dynamics and distribution, Velocity SMART ...
(Date:6/23/2016)... PUNE, India , June 23, 2016 /PRNewswire/ ... culture media market research report to its pharmaceuticals ... company profiles, product details and much more. ... market spread across 151 pages, profiling 15 companies ... now available at http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . ...
(Date:6/22/2016)... DUBLIN , June 22, 2016 Research ... and Global Markets" report to their offering. ... $39.4 billion in 2014 from $29.3 billion in 2013. The market ... (CAGR) of 13.8% from 2015 to 2020, increasing from $50.6 billion ... and projected product forecasts during the forecast period (2015 to 2020) ...
Breaking Biology Technology:
(Date:6/2/2016)... NEW YORK , June 2, 2016   The ... (Weather), is announcing Watson Ads, an industry-first capability in which ... advertising, by being able to ask questions via voice or ... Marketers have long ... with the consumer, that can be personal, relevant and valuable; ...
(Date:6/1/2016)... June 1, 2016 Favorable Government ... Administration and Criminal Identification to Boost Global Biometrics System ... released TechSci Research report, " Global Biometrics Market ... Forecast and Opportunities, 2011 - 2021", the global biometrics ... 2021, on account of growing security concerns across various ...
(Date:5/20/2016)... MINNEAPOLIS , May 20, 2016  VoiceIt ... technology partnership with VoicePass. By working ... user experience.  Because VoiceIt and VoicePass take slightly ... two engines increases both security and usability. ... expressed excitement about this new partnership. ...
Breaking Biology News(10 mins):